Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Predictive Questionnaires for Risk of Acute COPD (Chronic Obstructive Pulmonary Disease) Exacerbations
An update on a completed AstraZeneca-sponsored trial evaluating predictive questionnaires to assess the risk of acute COPD exacerbations. Th…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)
Clinical trial update reporting quality-of-life outcomes in adults with severe chronic obstructive pulmonary disease treated with Daxas (rof…
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Effect of GSK704838 In Healthy Volunteers [Phase 1]
Phase 1 clinical trial of the GSK704838 compound in healthy volunteers. COPD is listed as the related condition, and the study status is COM…
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease [NA]
A clinical trial update regarding a spot marching exercise test in chronic obstructive pulmonary disease; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of GSK233705 in combination with salmeterol in chronic obstructive pulmonary disease, compa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies. [Phase 4]
Phase 4 trial comparing Advair Diskus (fluticasone propionate/salmeterol) with Serevent Diskus (salmeterol) for preventing COPD exacerbation…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPD
A completed clinical trial updated quality-of-life outcomes in adults over 18 with severe COPD treated with Daxas (roflumilast).
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients [Phase 2]
Phase 2 trial evaluating repeat dosing of GSK159797 in asthmatic patients with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study to Assess GW642444 in Asthma Patients [Phase 2]
Phase 2 clinical trial of GW642444 has completed in patients with asthma and chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies. [Phase 4]
A Phase 4 trial comparing Advair Diskus (fluticasone propionate/salmeterol) with Serevent Diskus (salmeterol) in chronic obstructive pulmona…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients
This clinical trial update notes the completion of a Special Clinical Experience Investigation evaluating the long-term use of Symbicort Tur…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) [Phase 3]
A Phase 3 clinical trial in Chronic Obstructive Pulmonary Disease sponsored by GlaxoSmithKline has completed, and this entry provides a stat…
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease [Phase 1]
A Phase 1, multi-center inhalation study of R7103 in patients with COPD was withdrawn from the trial program; the study examined safety, tol…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: The Effect of a Respiratory Muscle Warm-up Prior to Exercise in Patients With Chronic Obstructive Pulmonary Disease [NA]
This clinical trial evaluated whether a respiratory muscle warm-up before exercise benefits patients with Chronic Obstructive Pulmonary Dise…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the efficacy and safety of roflumilast in Japanese patients aged over 40 with chronic obstru…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121) [Phase 3]
The HERO study is a Phase 3 trial evaluating roflumilast in patients with chronic obstructive pulmonary disease (COPD); the trial status is …
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08) [Phase 3]
A long-term Phase 3 study evaluating the safety and efficacy of roflumilast in Japanese patients over 40 with chronic obstructive pulmonary …
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Validation of the 1-minute Sit-to-stand Test in Patients With COPD [NA]
This update reports the completion of a clinical trial validating the 1-minute Sit-to-stand Test as a functional assessment in patients with…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD [NA]
This clinical trial update describes a study on inspiratory muscle training during pulmonary rehabilitation for COPD and notes that the tria…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 trial evaluating roflumilast during acute exacerbations of chronic obstructive pulmonary disease was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: SERETIDE Plus Tiotropium Versus Individual Components [Phase 2]
Phase 2 trial evaluating SERETIDE plus tiotropium versus the individual components in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients [Phase 3]
Company updates on the Phase 3 clinical trial evaluating the efficacy and safety of HCP1202 for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome)
This clinical trial update notes an event of acute dyspnea after non-invasive ventilation in patients with COPD and emphysema (deventilation…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy of Xuebijing Injection for acute exacerbations of chronic obstructive pulmonary disease;…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Home Rehabilitation Via Telemonitoring in Patients With COPD [NA]
A completed clinical study evaluating home rehabilitation via telemonitoring for patients with chronic obstructive pulmonary disease.